Meiji Seika Pharma Co. said on Dec. 25 it is seeking 10 million yen ($63,500) in damages from Kazuhiro Haraguchi, a Lower House member of the main opposition Constitutional Democratic Party of Japan.
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo; President and Representative Director: Daikichiro Kobayashi, hereinafter “Meiji”) announced that the company has concluded an investment ...
Meiji Seika Pharma Co., Ltd., a pharmaceutical company that develops, manufactures, and sells a range of products, announced the establishment of a local subsidiary, “Taiwan Meiji Pharma Co., Ltd.”, ...
gave the green light to CSL and Arcturus’ COVID-19 vaccine ARCT-154 – also known as Lunar-COV19 – which will be commercialised in Japan by partner Meiji Seika Pharma. Japan is the first ...
TOKYO, January 10, 2025--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo; President and Representative Director: Daikichiro Kobayashi, hereinafter "Meiji") announced that the ...
TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo, President: Daikichiro Kobayashi) announced the establishment of a local subsidiary, "Taiwan Meiji Pharma Co ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback